SEC Filings

SEC Filings

Filing date	Description	Form	View
Jul 10, 2009	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000080255-09-000557.pdf 0000080255-09-000557.rtf
Jun 24, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-032065.pdf 0001181431-09-032065.rtf
Jun 24, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-032067.pdf 0001181431-09-032067.rtf
Jun 24, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-032068.pdf 0001181431-09-032068.rtf
Jun 02, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-122988.pdf 0001193125-09-122988.rtf 0001193125-09-122988.xls
Jun 01, 2009	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001193125-09-122227.pdf 0001193125-09-122227.rtf 0001193125-09-122227.xls
Jun 01, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-028085.pdf 0001181431-09-028085.rtf
May 29, 2009	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001193125-09-121552.pdf 0001193125-09-121552.rtf 0001193125-09-121552.xls
May 14, 2009	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-09-111036.pdf 0001193125-09-111036.rtf 0001193125-09-111036.xls
May 11, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-107014.pdf 0001193125-09-107014.rtf 0001193125-09-107014.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE